The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling

Published:2015-09-18 Issue:2 Volume:14 Page:129-133
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

van Voorn George A. K.,Vemer Pepijn,Hamerlijnck Dominique,Ramos Isaac Corro,Teunissen Geertruida J.,Al Maiwenn,Feenstra Talitha L.

Funder

Netherlands Organisation for Health Research and Development

Zorginstituut Nederland (NL)

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40258-015-0200-7.pdf

Reference24 articles.

1. Kristensen FB, Mäkelä M, Neikter SA, Rehnqvist N, Håheim LL, Mørland B, et al. European network for Health Technology Assessment, EUnetHTA: planning, development, and implementation of a sustainable European network for Health Technology Assessment. Int J Technol Assess Health Care. 2009;25(S2):107–16.

2. Hall PS, McCabe C, Brown JM, Cameron DA. Health economics in drug development: efficient research to inform healthcare funding decisions. Eur J Cancer. 2010;46:2674–80.

3. Franken M, Le Polain M, Cleemput I, Koopmanschap M. Similarities and differences between five European drug reimbursement systems. Int J Technol Assess Health Care. 2013;28(4):349–57.

4. McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold. PharmacoEconomics. 2008;26:733–44.

5. Vemer P, Van Voorn GAK, Corro Ramos I, Krabbe PFM, Al M, Feenstra T. Improving model validation in HTA: comments on the guidelines of the ISPOR-SMDM Modeling Good Research Practices Task Force. Value Health. 2013;16(6):1106–7.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative: implications for decision making;Quality of Life Research;2024-08-08

2. Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment;Applied Health Economics and Health Policy;2024-03-30

3. Making Decision Models Fit for Purpose: The Importance of Ensuring Stakeholder Involvement;PharmacoEconomics;2024-01-18

4. Policy-making and implementation for newborn bloodspot screening in Europe: a comparison between EURORDIS principles and UK practice;The Lancet Regional Health - Europe;2023-10

5. Values in Modelling: Video Series Development and Evaluation Survey;Applied Health Economics and Health Policy;2023-07-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3